Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
(By Rachel Cohrs for STAT) WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey
Read More
Part D/Prescription Drugs
House passes bill to cap insulin prices
(By Barbara Sprunt for NPR) The House of Representatives voted Thursday to approve legislation that would limit cost-sharing for insulin
Read MoreKFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities
(By Ashley Kirzinger, Audrey Kearney, Mayesha Quasem , Mellisha Stokes , Liz Hamel, and Mollyann Brodie for Kaiser Family Foundation
Read MoreWith pharma still struggling in Alzheimer’s, health tech companies want a swing
(By Katie Palmer for STAT) In the wake of the first Alzheimer’s drug approval in nearly two decades, pharmaceutical companies
Read MoreDo I really need another booster? The answer depends on age, risk and timing
(By Maria Godoy, Allison Aubrey and Jane Greenhalgh for NPR) The Biden administration has given the go-ahead for another COVID
Read MoreOut-of-pocket spending on insulin among people with private insurance
(By Krutika Amin, Gary Claxton, Matthew Rae, and Cynthia Cox for Kaiser Family Foundation published March 24, 2022) The Build
Read MoreThe FDA is expected to authorize 2nd boosters for people 50 and up
(By Rob Stein and Jane Greenhalgh for NPR) Anyone 50 years and older could soon be eligible for a second
Read MoreTips on reviewing your Medicare Advantage plan
Many people switch to Medicare Advantage during the fall Medicare Annual Enrollment Period, not fully understanding how the plans work.
Read MoreDon’t wait: Medicare Advantage Open Enrollment ends March 31
(Source – www.medicare.gov/blog) Did you know that if you’re unhappy with your Medicare Advantage Plan (Medicare Part C), you have
Read MorePayer organizations respond to CMS’ Medicare Advantage, Part D proposed rule
(By Georgina Gonzalez for Becker’s Hospital Review) America’s Health Insurance Plans and the Alliance of Community Health Plans have commented
Read More